Suppr超能文献

CC趋化因子受体7的表达与B16小鼠黑色素瘤区域淋巴结转移

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

作者信息

Wiley H E, Gonzalez E B, Maki W, Wu M T, Hwang S T

机构信息

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

J Natl Cancer Inst. 2001 Nov 7;93(21):1638-43. doi: 10.1093/jnci/93.21.1638.

Abstract

BACKGROUND

CC chemokine receptor-7 (CCR7), which plays a critical role in the migration of activated dendritic cells to regional lymph nodes via afferent lymphatic vessels, is also expressed by human breast and melanoma cell lines. Because neoplastic cells also enter lymphatic vessels before metastasis to the lymph nodes, we investigated whether CCR7 expression enhances metastasis of B16 murine melanoma cells to regional lymph nodes.

METHODS

B16 cells were transduced with a retroviral vector containing CCR7 complementary DNA (CCR7-B16 cells) or with vector alone (pLNCX2-B16 control cells). The functional assay for CCR7 protein was Ca(2+) flux stimulated by the chemokine CCL21, a CCR7-specific ligand produced by lymphatic endothelial cells. B16 tumor cells were injected into the footpad of mice. Tumor cell metastasis to draining lymph nodes was assessed by measuring messenger RNA (mRNA) for tyrosinase-related protein-1 (TRP), a melanocyte-specific enzyme, with real-time, quantitative reverse transcription-coupled polymerase chain reaction. All statistical tests were two-sided.

RESULTS

One week after injection into the footpad, 701-fold (95% confidence interval [CI] = 64- to 1336-fold) more TRP mRNA was detected in draining lymph nodes from CCR7-B16 cell-injected mice than in those from control cell-injected mice. Three weeks after footpad injection, 58% (11 of 19) of the draining lymph nodes from CCR7-B16 cell-injected mice and 5% (one of 19) of those from control mice showed gross metastases (P<.001). CCR7-B16 cells isolated from lymph node metastases retained functional CCR7 expression. Lymph node metastasis of CCR7-B16 cells was blocked by neutralizing anti-CCL21 antibodies (metastasis in none of five lymph nodes) but not by control immunoglobulin G (three of five). Enhanced metastasis of CCR7-B16 cells was specific for a lymphatic route because both CCR7-B16 and control cells co-injected intravenously metastasized to the lung at the same frequency.

CONCLUSION

Expression of a single chemokine receptor gene, CCR7, increased B16 cell metastasis to draining lymph nodes, suggesting that cancer cells may co-opt normal mechanisms of lymph node homing during metastasis.

摘要

背景

C-C趋化因子受体7(CCR7)在活化的树突状细胞经输入淋巴管迁移至区域淋巴结的过程中起关键作用,人类乳腺癌和黑色素瘤细胞系也表达该受体。由于肿瘤细胞在转移至淋巴结之前也会进入淋巴管,我们研究了CCR7表达是否会增强B16小鼠黑色素瘤细胞向区域淋巴结的转移。

方法

用含有CCR7互补DNA的逆转录病毒载体转导B16细胞(CCR7-B16细胞),或仅用载体转导(pLNCX2-B16对照细胞)。CCR7蛋白的功能检测是通过趋化因子CCL21刺激Ca(2+)内流,CCL21是淋巴管内皮细胞产生的CCR7特异性配体。将B16肿瘤细胞注射到小鼠足垫中。通过实时定量逆转录聚合酶链反应测量酪氨酸酶相关蛋白-1(TRP,一种黑素细胞特异性酶)的信使RNA(mRNA),评估肿瘤细胞向引流淋巴结的转移情况。所有统计检验均为双侧检验。

结果

注射到足垫一周后,注射CCR7-B16细胞的小鼠引流淋巴结中检测到的TRP mRNA比注射对照细胞的小鼠多701倍(95%置信区间[CI]=64至1336倍)。足垫注射三周后,注射CCR7-B16细胞的小鼠中有58%(19个中的11个)引流淋巴结出现肉眼可见的转移,而对照小鼠中有5%(19个中的1个)出现转移(P<0.001)。从淋巴结转移灶中分离出的CCR7-B16细胞保留了功能性CCR7表达。CCR7-B16细胞的淋巴结转移被中和抗CCL21抗体阻断(5个淋巴结中均无转移),但未被对照免疫球蛋白G阻断(5个中有3个转移)。CCR7-B16细胞转移增强是淋巴管途径特有的,因为静脉内共同注射的CCR7-B16细胞和对照细胞转移至肺的频率相同。

结论

单一趋化因子受体基因CCR7的表达增加了B16细胞向引流淋巴结的转移,提示癌细胞在转移过程中可能利用了淋巴结归巢的正常机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验